• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    CME’s AI Compute Futures and Novel Index Products Could Be A Game Changer For CME Group (CME)

    Simply Wall St·08/15/2026 23:29:06
    Listen to the news
    • CME Group recently unveiled a wave of product initiatives, including index-based Hockey futures using NHL statistics, Compute futures tied to GPU rental costs with Silicon Data, expanded 24/7 trading for 100-Ounce Silver futures, and new E-nano equity index contracts for finer-grain exposure.
    • Together, these launches highlight CME Group’s push beyond traditional futures into AI infrastructure pricing, sports performance indexes, and retail-friendly metals and equity products, reinforcing its evolution into a multi-asset derivatives and data platform.
    • We’ll now examine how CME’s move into GPU-based Compute futures with Silicon Data could influence the company’s existing investment narrative.

    AI is about to change healthcare. These 44 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

    CME Group Investment Narrative Recap

    To own CME Group, you generally need to believe its core derivatives franchise and data business can keep attracting liquidity across asset classes, even if growth is moderate and competition intense. The recent wave of new contracts, particularly in AI-related compute and around-the-clock metals trading, does not materially change the near term focus on sustaining volumes in interest rate and equity futures, nor does it remove the key risk of lower volatility and trading activity reducing demand for hedging products.

    The upcoming Compute futures with Silicon Data, tied to GPU rental indexes for Nvidia H100 and B200 chips, look most directly connected to CME’s effort to deepen its toolkit for clients exposed to AI infrastructure costs. While still pending regulatory review, this launch sits alongside 24/7 retail sized metals contracts and nano equity index futures as part of a broader attempt to keep CME’s product set relevant to how investors and corporates try to manage risk today, which feeds into the volume and fee story investors care about.

    However, against this expansion, investors should still be aware of the risk that prolonged periods of muted market volatility could...

    Read the full narrative on CME Group (it's free!)

    CME Group's narrative projects $8.0 billion revenue and $4.6 billion earnings by 2029. This requires 5.6% yearly revenue growth and an earnings increase of about $0.3 billion from $4.3 billion today.

    Uncover how CME Group's forecasts yield a $282.36 fair value, a 5% upside to its current price.

    Exploring Other Perspectives

    CME 1-Year Stock Price Chart
    CME 1-Year Stock Price Chart

    Three Simply Wall St Community fair value estimates for CME Group range from US$243.69 to US$284.13, underscoring how far individual views can diverge. When you compare those opinions with CME’s reliance on volatility driven derivatives volumes, it becomes clear why exploring several different risk and return scenarios matters before forming your own view.

    Explore 3 other fair value estimates on CME Group - why the stock might be worth as much as 5% more than the current price!

    Form Your Own Verdict

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Interested In Other Possibilities?

    These stocks are moving-our analysis flagged them today. Act fast before the price catches up:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.